Issue: When do transactions involving pseudoephedrine constitute "regulated transactions?"
| Area of Law: | Healthcare & Pharmaceutical Law Compliance |
| Keywords: | Pseudoephedrine; Regulated transactions; Suspicious transaction reporting requirement |
| Jurisdiction: | Federal |
| Cited Cases: | None |
| Cited Statutes: | 21 U.S.C. § 830(b)(1)(A); 21 U.S.C. § 830 (a)(3); 21 C.F.R. § 1310.04 (f); 21 U.S.C. § 802(39)(A) |
| Date: | 12/01/2001 |
If a transaction is a "regulated transaction " then it is subject to the "suspicious transaction" reporting requirements of 21 U.S.C. § 830(b)(1)(A) and purchase identification requirement of 21 U.S.C. § 830 (a)(3). The Attorney General has established a "threshold amount" for pseudoephedrine at one kilogram per customer per month. 21 C.F.R. § 1310.04 (f). The only transactions that are regulated transactions are those made at or in excess of that cumulative monthly amount. See 21 U.S.C. § 802(39)(A).
[…]